Novartis AG
Use of alpha 7 nicotinic acetylcholine receptor agonists
Last updated:
Abstract:
The invention concerns the use of certain alpha 7 nicotinic acetylcholine receptor agonist for the facilitation of emergence from general anesthesia.
Status:
Grant
Type:
Utility
Filling date:
25 Aug 2017
Issue date:
26 Apr 2022